Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: wolfdog2 who wrote (685)	5/3/1998 4:37:00 PM
From: yosi s	Read Replies (1) \| Respond to of 1491

I guess the price goes down and the debate degenerates some what. Let me call your attention that short intrest is out and it is higher. So the down pressure could very well be from increase short selling. And if you ask why would some one shorts PARS. I think this is a repeat. Due to the new placement. Also if you check Bid to ask sales you will notice that there is a distribution on the sales side. The way I see it is the sellers are the Hedge Fund. They are in for the short run. PARS is still very little followed and is very volatile. They got 2 product on the market now and a third of the same is coming. HU211 is a big wild card. Info is limited but very encouraging. Tamoxiphen analogue is very early setting up for phase 1 . The Risk in PARS Lotemax and Alrex is the risk in BOL sales force. They are going thru reorganization. To summe it up Monday the stock will go up due to increase buying and with in 2 wks will be back close to it recents high. Next significant news will be HU211. relating to the first 2 sub groups of phase 2 study. Once out negotiation with future partner will take acceleraed phase. Best regards Yosi.

To: wolfdog2 who wrote (685)	5/3/1998 4:39:00 PM
From: InvestorLady	Read Replies (2) \| Respond to of 1491

<< I personally find your characterizations of his relationship with management and research insulting.>> I was not talking about his relationship with management but mine in the past that has caused me to make mistakes. This was an attempt to explain my interest in caution. Whatever, insults were not intended. There are some cautions I have obsereved regarding posting: overt exuberance , very defensive and childish reposts, and lack of substance to support the exuberance. The one that matters most is the last one. David is apparently a guru around these parts with a lot of knowledge in the industry, my apologies. You are correct, I am new to the board. It takes time to get up to speed. Forgive the intrusion. Regardless, lets save any future personal issues for private messages so people don't have to read the nonsense with the result being the focus can be on PARS and not the poster; to judge the company and the stock as an investment. We have money on the line, yes? I am looking into averaging down and if this drop is due to an arbing opportunity, that could be very interesting indeed. Does anyone know what the overhead supply is being arbed? <<The Risk in PARS Lotemax and Alrex is the risk in BOL sales force. They are going thru reorganization. >> Yosi, would you kindly explain more of this? How are they being reorganized? Lady